Mode
Text Size
Log in / Sign up

Case report and literature review highlights skin lesions as early AITL signs before lymphadenopathy

Case report and literature review highlights skin lesions as early AITL signs before lymphadenopathy
Photo by GeoNadir / Unsplash
Key Takeaway
Consider cutaneous manifestations as early but non-specific signs of AITL requiring lymph node biopsy for diagnosis.

This case report and literature review focuses on the cutaneous manifestations of Angioimmunoblastic T-cell lymphoma (AITL). The source describes a 63-year-old male patient who received chemotherapy with the miniCHOP regimen. The primary outcome reported was the diagnosis of AITL, while secondary outcomes included improvement in skin lesions and follow-up status.

The authors highlight that skin lesions improved after treatment in this specific case. However, they emphasize that skin lesions are often non-specific and diverse, which can lead to misdiagnosis and treatment delay. Cytological atypia is rarely reported, and clinical manifestations along with histopathology of skin lesions are frequently non-specific.

The review concludes that clinicians should be vigilant regarding cutaneous manifestations of AITL to ensure early and accurate diagnosis. Continuous observation is necessary for AITL patients who develop skin lesions prior to lymphadenopathy. The final diagnosis of AITL remains based on lymph node biopsy, as cutaneous signs alone are insufficient for confirmation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundAngioimmunoblastic T-cell lymphoma (AITL), a rare and aggressive subtype of T-cell lymphoma, affects the skin in up to 50% of cases. Its protean clinical and histopathological cutaneous manifestations pose a challenge in diagnosis, particularly when skin involvement precedes lymph node biopsy confirmation.Case presentationA 63-year-old male initially presented with progressive erythema and nodules, later developing vasculitis-like ulcers and generalized lymphadenopathy. The skin biopsy of erythema demonstrated mild perivascular lymphocytic infiltration around small blood vessels throughout the entire dermis, while the vasculitis-like ulcer biopsy demonstrated perivascular lymphocytic infiltration and small blood vessel hyperplasia. The final diagnosis of AITL was made through lymph node incisional biopsy based on morphology and immunohistochemistry. The patient received chemotherapy with the miniCHOP regimen. The skin lesions improved after treatment, and the patient remained under follow-up.ConclusionCutaneous manifestations of AITL are diverse, non-specific and can precede systemic symptoms. Histopathologically, cytological atypia is rarely reported. Immunohistochemistry for T-helper markers and molecular data is sometimes useful. However, both clinical manifestations and histopathology of skin lesions are often non-specific and diverse, leading to misdiagnosis and treatment delay. Continuous observation is necessary in AITL patients who develop skin lesions prior to lymphadenopathy, while the final diagnosis of AITL is still based on lymph node biopsy. Clinicians should be vigilant regarding the cutaneous manifestations of AITL to make an early and accurate diagnosis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.